SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: Paxton who wrote (392)8/1/2000 8:33:47 PM
From: Elmer  Respond to of 810
 
You are probably right about the analysts. It's the viability of gene therapy that may cause continued strength. Other than VICL, I can't think of another pure play in gene therapy (although I'm sure there are others). My point is that if gene therapy works, these stock could see major revaluations.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News